Score is driven almost entirely by the Roth Principal Investments ELOC signed 2026-06-30 and amended 2026-07-10 — a $25,000,000 VWAP-discount equity line with 31,750,000 resale shares registered on 2026-07-02, equal to 211% of the 14.7M float. This is a variable-rate transaction: purchases price at VWAP less a fixed 3.0% (Market Open/Intraday) or 5.0% (Pre/Post-Market, reduced from 6.0% on 2026-07-10) discount, giving the counterparty a structurally profitable same-day resale spread. Draw caps of up to 2,000,000 shares or 25% of valuation-period volume per purchase mean Roth can absorb a quarter of daily volume on demand — on a ~$11M market cap, that is a persistent bid-side drag. This scores heavily under the 40% convertibles/variable-rate component even though draws are company-discretionary rather than holder-forced. Recent activity (20% component) is near-maximal: the company sold 3,713,939 ATM shares in FY2025, 2,371,943 more in Q1 2026, and another 2,104,742 between 2026-04-01 and 2026-05-12 — roughly $9.37M of ATM stock sold to date and a 434% share count increase from 2,745,684 (2024-08-09) to 15,040,679 (2026-06-23). Historical pattern (10% component) is maximal: three reverse splits (1:10 in 2017, 1:20 in 2019, 1:40 in 2024), two warrant inducement repricings, and four Series C expiration extensions. The one genuine mitigant, which caps the score at 8 rather than 9-10: the warrant book (30% component) is entirely out of the money — every one of the 7,777,803 warrants sits at $1.25 or higher against a $0.76 stock (the nearest, Series E at $1.25, is 64% away), and the filings explicitly state the warrants had NO intrinsic value at 2026-03-31. There are no convertible notes and zero debt. Two hard brakes also throttle near-term ELOC velocity: the $0.50 Threshold Price floor and, more importantly, the Nasdaq 3,004,114-share Exchange Cap (19.99%) which BINDS at the current $0.76 price because the $0.9853 average-price exemption is not met and stockholder approval has not been obtained. Absent a shareholder vote, near-term ELOC supply is legally limited to ~3.0M shares, not 31.75M.